Preface
From the bench to the bedside—promoting the roles of nurses and allied health professionals in the management of lung cancer and mesothelioma
Translational Lung Cancer Research
2016;
5
(3)
:214-215
.
(30 June 2016)
Original Article
Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project
Translational Lung Cancer Research
2016;
5
(3)
:216-218
.
(30 June 2016)
Perspective
Ethical challenges in conducting clinical research in lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:219-226
.
(30 June 2016)
Review Article
The lung cancer nurse role in the management of paraneoplastic syndromes in lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:227-234
.
(30 June 2016)
The importance of exercise in lung cancer treatment
Translational Lung Cancer Research
2016;
5
(3)
:235-238
.
(30 June 2016)
Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:239-243
.
(30 June 2016)
Mini-Review
The role of the occupational therapist in the care of people living with lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:244-246
.
(30 June 2016)
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)2
Pros: Should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?
Translational Lung Cancer Research
2016;
5
(3)
:247-250
.
(30 June 2016)
Cons: Should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?
Translational Lung Cancer Research
2016;
5
(3)
:251-253
.
(30 June 2016)
Rebuttal from Dr. Obiols and Dr. Call
Translational Lung Cancer Research
2016;
5
(3)
:254-255
.
(30 June 2016)
Rebuttal from Dr. Decaluwé and Dr. Dooms
Translational Lung Cancer Research
2016;
5
(3)
:256-257
.
(30 June 2016)
Evidence-Based Medicine3
Prognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysis
Translational Lung Cancer Research
2016;
5
(3)
:258-264
.
(30 June 2016)
Original Article
Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index
Translational Lung Cancer Research
2016;
5
(3)
:265-271
.
(30 June 2016)
Review Article
Lung cancer stem cells—characteristics, phenotype
Translational Lung Cancer Research
2016;
5
(3)
:272-279
.
(30 June 2016)
Anticoagulation, ferrotoxicity and the future of translational lung cancer research
Translational Lung Cancer Research
2016;
5
(3)
:280-287
.
(30 June 2016)
Non-small cell lung cancer: current treatment and future advances
Translational Lung Cancer Research
2016;
5
(3)
:288-300
.
(30 June 2016)
Tackling ALK in non-small cell lung cancer: the role of novel inhibitors
Translational Lung Cancer Research
2016;
5
(3)
:301-321
.
(30 June 2016)
Mini-Review
A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:322-330
.
(30 June 2016)
Editorial
Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving past common point mutations or indels into uncommon kinase domain duplications and rearrangements
Translational Lung Cancer Research
2016;
5
(3)
:331-337
.
(30 June 2016)
Digital detection of T790M—yes or no to an ultrasensitive assay
Translational Lung Cancer Research
2016;
5
(3)
:338-342
.
(30 June 2016)
Commentary
Alectinib—a new chapter in the management of ALK-positive lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:343-346
.
(30 June 2016)
Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer
Translational Lung Cancer Research
2016;
5
(3)
:347-349
.
(30 June 2016)
Case Report
Primitive neuroectodermal tumor of lungs in adults: a rare series of three cases treated with upfront chemo-radiation
Translational Lung Cancer Research
2016;
5
(3)
:350-355
.
(30 June 2016)
Recurrent “pneumonia” in left lower lobe lasting for 8 years: a case report
Translational Lung Cancer Research
2016;
5
(3)
:356-362
.
(30 June 2016)
Disclosure:
1. The focused issue “The role of Nurses and Allied Health Professionals in lung cancer and mesothelioma care” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. John White served as the unpaid Guest Editor for the focused issue.
2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
3. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
